Management of irritable bowel syndrome in the patient with ulcerative colitis

Philip M. Ginsburg, Theodore M. Bayless

Research output: Chapter in Book/Report/Conference proceedingChapter


Irritable bowel syndrome (IBS) is one of the most common disorders in gastroenterology, affecting 10–15 % of the US population and accounting for one-quarter to one-half of all visits to digestive health specialists. With such a high prevalence, it may be inferred that a significant number of patients with ulcerative colitis (UC) also suffer from coexisting IBS. Indeed, it is widely believed that the prevalence of IBS is greater in patients with inflammatory bowel disease (IBD), affecting an estimated one-third of UC patients in remission. Recent research demonstrating a possible association between low-grade inflammation and IBS highlights the interconnecting relationship between inflammatory and functional disorders.

Original languageEnglish (US)
Title of host publicationMedical Therapy of Ulcerative Colitis
PublisherSpringer New York
Number of pages8
ISBN (Electronic)9781493916771
ISBN (Print)9781493916764
StatePublished - Jan 1 2014


  • Diarrhea
  • IPAA
  • Inflammation
  • Irritable bowel syndrome
  • Prevalence
  • Proctosigmoiditis
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Management of irritable bowel syndrome in the patient with ulcerative colitis'. Together they form a unique fingerprint.

Cite this